Edition:
United Kingdom

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

36.38CNY
15 Dec 2017
Change (% chg)

¥0.00 (+0.00%)
Prev Close
¥36.38
Open
¥36.20
Day's High
¥36.44
Day's Low
¥35.92
Volume
2,107,611
Avg. Vol
4,682,818
52-wk High
¥44.90
52-wk Low
¥34.70

Chart for

About

TASLY PHARMACEUTICAL GROUP CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical products. The Company provides traditional Chinese medicines, chemical preparations, chemical raw materials and biological drugs. The Company's products are applied in the treatment of... (more)

Overall

Beta: 0.57
Market Cap(Mil.): ¥37,978.73
Shares Outstanding(Mil.): 1,080.48
Dividend: 0.56
Yield (%): 1.59

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Tasly Pharmaceutical's unit gets approval to issue up to 1 bln yuan asset-backed securities

* SAYS UNIT GETS APPROVAL TO ISSUE UP TO 1.0 BILLION YUAN ($151.56 million) ASSET-BACKED SECURITIES Source text in Chinese: http://bit.ly/2zBfelT Further company coverage: ($1 = 6.5979 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

29 Nov 2017

BRIEF-Tasly Pharmaceutical's 9-month net profit up 13.5 pct y/y

Oct 25 Tasly Pharmaceutical Group Co Ltd * Says 9-month net profit up 13.5 percent y/y Source text in Chinese: http://bit.ly/2z6sn9J Further company coverage: (Reporting by Hong Kong newsroom)

25 Oct 2017

BRIEF-Tasly Pharmaceutical's H1 net profit up 10.4 pct y/y at 756.2 mln yuan

* Says H1 net profit up 10.4 percent y/y at 756.2 million yuan ($113.25 million)

15 Aug 2017

BRIEF-Tasly Pharma gets regulatory approval to issue up to 800 mln yuan bonds

* Says it gets securities regulator's approval to issue up to 800 million yuan ($116.98 million) bonds

23 Jun 2017

Earnings vs. Estimates